Established in 1957, the cardiology department is the first specialized cardiovascular department in Shanghai. It is a State Key Clinical Specialty appointed by Ministry of Health, a Key Discipline appointed by Ministry of Education, one of the first standardized training bases of cardiologists, an “all trans-catheter therapeutic techniques” training base of cardiovascular interventional diagnosis and treatment technology appointed by Ministry of Health (intervention for coronary heart disease, structural heart disease and cardiac arrhythmia), and the only cardiovascular training base for core curriculum of 8-year clinical medicine program of Shanghai Jiao Tong University, School of Medicine.
As the cardiology department specializing in cardiovascular and pulmonary diseases, it has trained numerous elite cardiologists for 60 years, and it is one of the few cardiology departments in China that have integrated licensed Chest Pain Center, Atrial Fibrillation Center, and Heart Failure Center simultaneously. Meanwhile, it is an affiliated unit of Quality Control of China Chest Pain Center.
The department experts in various cardiovascular and pulmonary vascular diseases, especially in difficult and intractable diseases, and has established its own characteristics in the fields of coronary artery disease (CAD), cardiac arrhythmia, congenital heart disease, valvular heart disease (VHD), cardiomyopathy, heart failure and so on. With superior proficiency in transcatheter interventional diagnosis and treatment for various types of cardiovascular diseases, the department has actively applied new technologies into clinical practice, including “one-stop” therapy for atrial fibrillation (AF) (left atrial appendage occlusion (LAAO) + radiofrequency catheter ablation (RFCA)), physiological pacing such as His-bundle/left bundle branch pacing, excimer laser coronary atherectomy, transcatheter aortic/pulmonary valve replacement, andpulmonary vein stenting.
The department stays at the domestic leading edge in the fields of complex CAD intervention, reperfusion therapeutic strategy formulation for acute myocardial infarction (AMI) and microcirculation protection, comprehensive management for AF (RFCA, LAAO, anticoagulation and etc.), VHD intervention, cardiopulmonary vascular abnormalities intervention, and frontier cardiac pacing technique, with substantial international influence especially in the Asian-Pacific region, and the number of RFCA cases for AF has topped Asian-Pacific region for many years. Moreover, the department holds an advanced position nationwide in areas of critical cardiovascular disease treatment and medical & surgical comprehensive treatment for end-stage heart failure.
Equipped with approximately 200 beds currently, the department has a CCU ward, a cardiac catheterization laboratory with five DSA systems, a hybrid operation room and a translational cardiovascular medical center covering over 1,000 square meters. With abundant professional strength and complete echelon construction, the talent team included one Ministry-of-Health-nominated young and middle-aged expert with prominent contributions, three recipients of the State Council Special Allowance, one Shanghai Leading Talent, one Shanghai Leading Medical Talent, two second-grade professors, three doctoral supervisors, four master supervisors, and 80 percent of the staff own doctor’s degree.
The department aims at “Be the Best Cardiology Department,” and endeavors to achieve “acquire what others haven’t, master what others acquire, and heighten what others master.” It implements the idea of patient-oriented, takes “base on Shanghai, serve the country, and face the world” as its own duty, and provides medical service of quality and consideration to patients.